直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through May 31, 2020

August 12, 2020

Authored and Edited by Daniel F. Klodowski; Eric A. Liu; Jason E. Stach; Elliot C. Cook

Through May 31, 2020, the Federal Circuit decided 740 PTAB appeals from IPRs and CBMs.  The Federal Circuit affirmed the PTAB on every issue in 541 (73.11%) cases and reversed or vacated the PTAB on every issue in 101 (13.65%) cases.  A mixed outcome on appeal, where at least one issue was affirmed and at least one issue was vacated or reversed, occurred in 70 (9.46%) cases. 

The court also dismissed 28 (3.78%) appeals without rendering a decision on the merits.  Dismissals may occur, for example, where the Federal Circuit determines that it does not have jurisdiction to hear an appeal, such as in certain appeals from PTAB institution decisions.    

Breaking down the numbers further, in its appeals from IPRs, the Federal Circuit affirmed the PTAB on every issue in 505 (72.87%) cases, reversed or vacated the PTAB on every issue in 97 (14%) cases, issued a mixed outcome in 67 (9.67%) cases, and dismissed 24 (3.46%) cases. 

In CBM appeals, the Federal Circuit affirmed the PTAB on every issue in 36 (76.60%) cases, issued a mixed outcome in 3 (6.38%) cases, dismissed 4 (8.51%) cases, and reversed or vacated the PTAB on every issue in 4 (8.51%) cases.

 

An important tool helping the Federal Circuit manage its significant docket of PTAB appeals is the Rule 36 affirmance, through which the court affirms the PTAB without rendering a full, written opinion.  Of the 740 IPR and CBM appeals it has considered thus far, the Federal Circuit issued Rule 36 affirmances in 338 (45.68%) cases.  The court issued written opinions, including affirmances, reversals, dismissals, and mixed decisions, in 402 (54.32%) cases.  The number of issued Rule 36 affirmances has generally trended downward over time.

The summary affirmance rate for IPR appeals closely tracks the combined average with CBMs, perhaps unsurprisingly due to the relatively high proportion of appeals from IPR proceedings.  The Federal Circuit issued written decisions in 375 (54.11%) IPR appeals, and issued summary affirmances in 318 (45.89%) appeals.

The summary affirmance rate for CBM appeals, however, is currently somewhat lower than in IPRs.  The Federal Circuit issued summary affirmances in 20 (42.55%) CBM appeals, and issued written decisions in 27 (57.45%) CBM appeals.

Stay tuned to the AIA Blog for the latest updates, analysis, and statistics on all aspects of PTAB and Federal Circuit practice.  Subscribe to the AIA Blog at the bottom of the page to receive notifications of new posts via email.

Tags

America Invents Act (AIA), AIA statistics, United States Court of Appeals for the Federal Circuit (CAFC)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Offices

Atlanta, GA

Reston, VA

Washington, DC

Contacts

Daniel F. Klodowski
Partner
Washington, DC
+1 202 408 4216
Email
Jason E. Stach
Partner
Atlanta, GA
+1 404 653 6428
Email
Elliot C. Cook
Partner
Reston, VA
+1 571 203 2738
Email

Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.

Related Insights

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge 

May 5, 2026

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Federal Circuit IP Blog

Federal Circuit Affirms District Court’s Invalidation of Patents Because Inventorship Could Not Be Corrected Without Giving All Inventors Notice and an Opportunity to Be Heard

April 22, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP